ClinicalTrials.gg
Drug

Larazotide acetate clinical trials

Also written INN-202 and AT-1001.

Its developmentBy 9 Meters Biopharma, BioMarin Pharmaceutical and Interlude Biopharma, step by step12 company-led studies, furthest phase 3: when each phase was reached, its deals, target and what is ahead.

A product of Larazotide; its studies count on that page too.

studies test it
13
open now
1
in phase 3
1
first study started
2005

How each study uses larazotide acetate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the larazotide acetate studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

larazotide acetate
10
AT1001
3

Development codes

INN-202
7
AT-1001
6

Studies by the year they started

12 studies that test it; most in 2011 (4); 1 more planned to start later

Studies that test larazotide acetate, by start year
YearStudies
20051
20062
20071
20081
20091
20114
20211
20231

By phase

A phase 1/2 study counts in both.

Phase 1
5
Phase 2
7
Phase 3
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 11 · Other 2

9 Meters Biopharma, Inc. (7) · Amicus Therapeutics (3) · Massachusetts General Hospital (2) · Interlude Biopharma Co. (1)

Often tested with

Tested in the same studies.

Migalastat (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses larazotide acetate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 13

What changed recently

From the registry's own updates since Oct 20, 2026.

Codes

What other systems call larazotide acetate · ClinicalTrials.gg INT005200

  • MeSH (NLM) C525167larazotide acetateOne source NLM
  • UNII (FDA) FO8S2IW40NLARAZOTIDE ACETATEConfirmed FDA, NLM
  • NCI Thesaurus C81670Larazotide AcetateOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.